144 related articles for article (PubMed ID: 18759697)
1. Stathmin 1: a novel therapeutic target for anticancer activity.
Rana S; Maples PB; Senzer N; Nemunaitis J
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1461-70. PubMed ID: 18759697
[TBL] [Abstract][Full Text] [Related]
2. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy.
Mistry SJ; Atweh GF
Mt Sinai J Med; 2002 Oct; 69(5):299-304. PubMed ID: 12415323
[TBL] [Abstract][Full Text] [Related]
3. Upregulated Op18/stathmin activity causes chromosomal instability through a mechanism that evades the spindle assembly checkpoint.
Holmfeldt P; Sellin ME; Gullberg M
Exp Cell Res; 2010 Jul; 316(12):2017-26. PubMed ID: 20399773
[TBL] [Abstract][Full Text] [Related]
4. The role of stathmin in the regulation of the cell cycle.
Rubin CI; Atweh GF
J Cell Biochem; 2004 Oct; 93(2):242-50. PubMed ID: 15368352
[TBL] [Abstract][Full Text] [Related]
5. Stathmin 1 is a potential novel oncogene in melanoma.
Chen J; Abi-Daoud M; Wang A; Yang X; Zhang X; Feilotter HE; Tron VA
Oncogene; 2013 Mar; 32(10):1330-7. PubMed ID: 22665054
[TBL] [Abstract][Full Text] [Related]
6. Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages.
Rowlands DC; Williams A; Jones NA; Guest SS; Reynolds GM; Barber PC; Brown G
Lab Invest; 1995 Jan; 72(1):100-13. PubMed ID: 7837783
[TBL] [Abstract][Full Text] [Related]
7. Coordinated expression of stathmin family members by far upstream sequence element-binding protein-1 increases motility in non-small cell lung cancer.
Singer S; Malz M; Herpel E; Warth A; Bissinger M; Keith M; Muley T; Meister M; Hoffmann H; Penzel R; Gdynia G; Ehemann V; Schnabel PA; Kuner R; Huber P; Schirmacher P; Breuhahn K
Cancer Res; 2009 Mar; 69(6):2234-43. PubMed ID: 19258502
[TBL] [Abstract][Full Text] [Related]
8. Taxol and anti-stathmin therapy: a synergistic combination that targets the mitotic spindle.
Iancu C; Mistry SJ; Arkin S; Atweh GF
Cancer Res; 2000 Jul; 60(13):3537-41. PubMed ID: 10910066
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.
Fang L; Min L; Lin Y; Ping G; Rui W; Ying Z; Xi W; Ting H; Li L; Ke D; Jihong R; Huizhong Z
Cell Signal; 2010 Jan; 22(1):166-73. PubMed ID: 19786090
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells.
Brattsand G; Roos G; Marklund U; Ueda H; Landberg G; Nånberg E; Sideras P; Gullberg M
Leukemia; 1993 Apr; 7(4):569-79. PubMed ID: 8464235
[TBL] [Abstract][Full Text] [Related]
11. Suspected leukemia oncoproteins CREB1 and LYL1 regulate Op18/STMN1 expression.
San-Marina S; Han Y; Liu J; Minden MD
Biochim Biophys Acta; 2012; 1819(11-12):1164-72. PubMed ID: 23000483
[TBL] [Abstract][Full Text] [Related]
12. Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis.
Larsson N; Marklund U; Gradin HM; Brattsand G; Gullberg M
Mol Cell Biol; 1997 Sep; 17(9):5530-9. PubMed ID: 9271428
[TBL] [Abstract][Full Text] [Related]
13. STMN1 overexpression correlates with biological behavior in human cutaneous squamous cell carcinoma.
Li X; Wang L; Li T; You B; Shan Y; Shi S; Qian L; Cao X
Pathol Res Pract; 2015 Nov; 211(11):816-23. PubMed ID: 26235036
[TBL] [Abstract][Full Text] [Related]
14. Stathmin 1 deficiency induces erythro-megakaryocytic defects leading to macrocytic anemia and thrombocythemia in Stathmin 1 knock out mice.
Ramlogan-Steel CA; Steel JC; Fathallah H; Iancu-Rubin C; Atweh GF
Blood Cells Mol Dis; 2021 Mar; 87():102522. PubMed ID: 33260083
[TBL] [Abstract][Full Text] [Related]
15. Aneugenic activity of Op18/stathmin is potentiated by the somatic Q18-->e mutation in leukemic cells.
Holmfeldt P; Brännström K; Stenmark S; Gullberg M
Mol Biol Cell; 2006 Jul; 17(7):2921-30. PubMed ID: 16624860
[TBL] [Abstract][Full Text] [Related]
16. Characterization and detection of cellular and proteomic alterations in stable stathmin-overexpressing, taxol-resistant BT549 breast cancer cells using offgel IEF/PAGE difference gel electrophoresis.
Balasubramani M; Nakao C; Uechi GT; Cardamone J; Kamath K; Leslie KL; Balachandran R; Wilson L; Day BW; Jordan MA
Mutat Res; 2011 Jun; 722(2):154-64. PubMed ID: 20816848
[TBL] [Abstract][Full Text] [Related]
17. Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery.
Wang Z; Jay CM; Evans C; Kumar P; Phalon C; Rao DD; Senzer N; Nemunaitis J
Toxicol Sci; 2017 Feb; 155(2):400-408. PubMed ID: 27815492
[TBL] [Abstract][Full Text] [Related]
18. Stathmin is overexpressed in malignant mesothelioma.
Kim JY; Harvard C; You L; Xu Z; Kuchenbecker K; Baehner R; Jablons D
Anticancer Res; 2007; 27(1A):39-44. PubMed ID: 17352214
[TBL] [Abstract][Full Text] [Related]
19. The microtubule-destabilizing activity of metablastin (p19) is controlled by phosphorylation.
Horwitz SB; Shen HJ; He L; Dittmar P; Neef R; Chen J; Schubart UK
J Biol Chem; 1997 Mar; 272(13):8129-32. PubMed ID: 9079624
[TBL] [Abstract][Full Text] [Related]
20. STNM1 in human cancers: role, function and potential therapy sensitizer.
Liu R; Liang X; Guo H; Li S; Yao W; Dong C; Wu J; Lu Y; Tang J; Zhang H
Cell Signal; 2023 Sep; 109():110775. PubMed ID: 37331415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
